相似文献
1
Repurposing the Pap smear: one step closer to gynecologic cancer screening.
Sci Transl Med. 2013 Jan 9;5(167):167ps1. doi: 10.1126/scitranslmed.3005411.
2
Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.
Sci Transl Med. 2013 Jan 9;5(167):167ra4. doi: 10.1126/scitranslmed.3004952.
3
Retooling the pap smear for ovarian and endometrial cancer detection.
Clin Chem. 2014 Jan;60(1):22-4. doi: 10.1373/clinchem.2013.204933. Epub 2013 Sep 16.
4
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.
Sci Transl Med. 2018 Mar 21;10(433). doi: 10.1126/scitranslmed.aap8793.
5
Incidental finding of abnormal cervical pathology in hysterectomy specimens after normal preoperative Papanicolaou smears in Thammasat University Hospital.
Asian Pac J Cancer Prev. 2014;15(14):5811-4. doi: 10.7314/apjcp.2014.15.14.5811.
6
The Diagnostic Value of Routine Papanicolaou Smears for Detecting Endometrial Cancers: An Update.
Acta Cytol. 2015;59(4):315-8. doi: 10.1159/000438975. Epub 2015 Aug 29.
7
Case report: detection of an advanced ovarian malignancy by cervical cytology.
S D J Med. 2003 Oct;56(10):427-9.
8
Test for ovarian, endometrial cancers. Could cells taken from a Pap test offer the first-ever early screening method?
Harv Womens Health Watch. 2013 Apr;20(8):5.
9
A Pap-Based Test to Detect Endometrial and Ovarian Cancers Early.
JAMA. 2018 May 8;319(18):1853. doi: 10.1001/jama.2018.5413.
10
How useful are cervical Pap smears in detecting endometrial carcinomas? A tertiary cancer center experience.
Diagn Cytopathol. 2021 Jan;49(1):127-131. doi: 10.1002/dc.24609. Epub 2020 Sep 10.
引用本文的文献
1
The clinical significance of occult gynecologic primary tumours in metastatic cancer.
Curr Oncol. 2017 Oct;24(5):e368-e378. doi: 10.3747/co.24.3594. Epub 2017 Oct 25.
本文引用的文献
1
Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.
Genome Res. 2012 Nov;22(11):2120-9. doi: 10.1101/gr.137596.112. Epub 2012 Oct 1.
2
Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.
J Natl Cancer Inst. 2012 Oct 3;104(19):1503-13. doi: 10.1093/jnci/djs345. Epub 2012 Aug 23.
3
Liquid-based Papanicolaou tests in endometrial carcinoma diagnosis. Performance, error root cause analysis, and quality improvement.
Am J Clin Pathol. 2012 Feb;137(2):248-54. doi: 10.1309/AJCPLFBK1A2XJDQI.
4
Cancer statistics, 2012.
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
5
Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan.
Clin Cancer Res. 2012 Feb 15;18(4):1177-85. doi: 10.1158/1078-0432.CCR-11-0564. Epub 2012 Jan 6.
6
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.
Genome Res. 2012 Feb;22(2):220-31. doi: 10.1101/gr.123497.111. Epub 2011 Oct 11.
7
High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability.
Cancer Discov. 2011 Jul;1(2):170-85. doi: 10.1158/2159-8290.CD-11-0039. Epub 2011 Jun 7.
8
Integrated genomic analyses of ovarian carcinoma.
Nature. 2011 Jun 29;474(7353):609-15. doi: 10.1038/nature10166.
9
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
JAMA. 2011 Jun 8;305(22):2295-303. doi: 10.1001/jama.2011.766.
10
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.
Lancet Oncol. 2011 Jan;12(1):38-48. doi: 10.1016/S1470-2045(10)70268-0. Epub 2010 Dec 10.
Zotero 插件